Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Pharmacokinetic data support use of oral deferasirox in transfusional hemosiderosis

June 27, 2003

Pfizer researchers describe new neuronal nAChR ligands for nicotine addiction

June 23, 2003

Second phase IIa study for TA-CD in cocaine dependence reports findings

June 19, 2003

Agents for iron overload therapy disclosed by Novartis researchers

June 3, 2003

Nippon Shinyaku acquires Japanese rights to acamprosate

May 28, 2003

Rat study suggests potential of topiramate in treating nicotine addiction

May 8, 2003

Ilomastat successful in treating exposure to mustard gas

April 24, 2003

Elite develops opioid antagonist product to minimize abuse potential

April 17, 2003

TA-CD enters phase IIa cocaine administration study

April 16, 2003

Evidence for potential of SB-277011-A in drug dependence and psychosis

April 11, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.